Acquisition Announced

InMed Pharmaceuticals acquisition of Mentari Therapeutics

Announced 19 May 2026

Advisers

Mentari Therapeutics

Target

Financial adviser
Legal adviser

InMed Pharmaceuticals

Acquirer

Financial adviser
Legal adviser
Target
Mentari Therapeutics
Acquirer
InMed Pharmaceuticals
Target based in
United States (unverified)
Buyer based in
Canada (unverified)
Sector
Biotech
Tags
Biotech, Pharma

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.